Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) Stock Short Interest Rises 76.8%

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 56,196 shares, an increase of 76.8% from the September 30th total of 31,793 shares. Based on an average daily trading volume, of 15,975 shares, the days-to-cover ratio is currently 3.5 days.

Medexus Pharmaceuticals Stock Performance

Shares of Medexus Pharmaceuticals stock traded down $0.04 on Friday, hitting $3.56. 1,030 shares of the company’s stock traded hands, compared to its average volume of 13,084. Medexus Pharmaceuticals has a one year low of $1.80 and a one year high of $3.96. The firm’s 50-day moving average price is $3.56 and its two-hundred day moving average price is $2.98.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company focused on acquiring, commercializing and supporting differentiated prescription products in North America. The company serves healthcare providers and patients primarily in the United States and Canada, with an emphasis on products addressing specialty and underserved therapeutic markets.

Medexus’ portfolio has included IXINITY, a recombinant factor IX replacement therapy used to prevent and control bleeding in people with hemophilia B; Rasuvo, a single-dose subcutaneous methotrexate injection used for certain rheumatoid arthritis and juvenile idiopathic arthritis patients; and Gleolan, an oral diagnostic imaging agent used during surgery to help visualize malignant glioma tissue.

The company’s business model is centered on licensing, acquiring and commercializing pharmaceutical products rather than conducting broad-based drug discovery.